We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · November 01, 2021

Drug-Eluting Stents for LAD or Left Main Coronary Artery Revascularization

Journal of the American Heart Association


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Heart Association
Drug-Eluting or Bare-Metal Stents for Left Anterior Descending or Left Main Coronary Artery Revascularization
J Am Heart Assoc 2021 Oct 19;10(20)e018828, R Piccolo, KH Bonaa, O Efthimiou, O Varenne, P Urban, C Kaiser, L Räber, A de Belder, W Remkes, AWJ Van't Hof, G Stankovic, PA Lemos, T Wilsgaard, J Reifart, AE Rodriguez, EE Ribeiro, PWJC Serruys, A Abizaid, M Sabaté, RA Byrne, JM de la Torre Hernandez, W Wijns, G Esposito, P Jüni, S Windecker, M Valgimigli

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading